Education
About Us
Working with TipRanks
Follow Us
Qrons (QRON)
:QRON
QRON Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.14 - $0.24
Previous CloseN/A
Volume60.00
Average Volume (3M)439.00
Market Cap
$2.44M
Enterprise ValueN/A
Total Cash (Recent Filing)$2.14K
Total Debt (Recent Filing)$296.00K
Price to Earnings (P/E)―
Beta-0.48
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding17,914,999
10 Day Avg. Volume1,319
30 Day Avg. Volume439
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Qrons News
---
QRON FAQ
What was Qrons ’s price range in the past 12 months?
Qrons lowest stock price was $0.14 and its highest was $0.24 in the past 12 months.
What is Qrons ’s market cap?
Qrons ’s market cap is $2.44M.
When is Qrons ’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Qrons ’s earnings last quarter?
Currently, no data Available
Is Qrons overvalued?
According to Wall Street analysts Qrons ’s price is currently Overvalued.
Does Qrons pay dividends?
Qrons does not currently pay dividends.
What is Qrons ’s EPS estimate?
Qrons ’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Qrons have?
Qrons has 17,914,999 shares outstanding.
What happened to Qrons ’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Qrons ?
Currently, no hedge funds are holding shares in QRON
---
Company Description
Qrons
Qrons Inc., a biotechnology company, engages in development of biotech products, treatments, and technologies to combat neuronal diseases. Its product candidates include QS100, an injury specific, 3D printable, implantable mesenchymal stem cells (MSCs)-synthetic hydrogel to treat penetrating brain injuries; and QS200, an injectable MSCs-synthetic hydrogel for the treatment of concussions and other diffused axonal injuries. The company was formerly known as BioLabMart Inc. and changed its name to Qrons Inc. in August 2017. Qrons Inc. was incorporated in 2016 and is based in Long Island City, New York.
---
Technical Analysis
Qualigen Therapeutics
―
Aptevo Therapeutics
―
Enveric Biosciences
―
CNS Pharmaceuticals
―
Revelation Biosciences
―
---